Skip to main content
logo
XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
2.490
-0.020 (-0.80%)
Mar 30, 2026, 12:34 PM EDT - Market open

XTL Biopharmaceuticals Revenue

XTL Biopharmaceuticals had revenue of $258.50K in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to $968.00K. In the year 2024, XTL Biopharmaceuticals had annual revenue of $451.00K.

Revenue (ttm)
$968.00K
Revenue Growth
n/a
P/S Ratio
6.53
Revenue / Employee
$96,800
Employees
10
Market Cap
6.32M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024451.00K--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Jan 1, 2019 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Cue Biopharma27.47M
Neuphoria Therapeutics14.99M
Barinthus Biotherapeutics14.97M
Curis9.44M
Marker Therapeutics3.55M
IGC Pharma1.11M
Daré Bioscience1.03M
Vistagen Therapeutics789.00K
Revenue Rankings

XTLB News

More News